Genetics: Update on Prenatal Screening and Diagnosis

Mark I. Evans, Stephanie Andriole, Shara M. Evans

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations

Abstract

There have been tremendous advances in the ability to screen for the "odds" of having a genetic disorder (both mendelian and chromosomal). With microarray analyses on fetal tissue now showing a minimum risk for any pregnancy being at least 1 in 150 and ultimately greater than 1%, it is thought that all patients, regardless of age, should be offered chorionic villus sampling/amniocentesis and microarray analysis. As sequencing techniques replace other laboratory methods, the only question will be whether these tests are performed on villi, amniotic fluid cells, or maternal blood.

Original languageEnglish
Pages (from-to)193-208
Number of pages16
JournalObstetrics and Gynecology Clinics of North America
Volume42
Issue number2
DOIs
StatePublished - 1 Jun 2015

Keywords

  • Amniocentesis
  • Chorionic villus sampling
  • Chromosomal
  • Fetal reduction
  • Genetic disorder
  • Mendelian
  • Multiple pregnancies
  • Pre-implantation diagnosis

Fingerprint

Dive into the research topics of 'Genetics: Update on Prenatal Screening and Diagnosis'. Together they form a unique fingerprint.

Cite this